Tirzepatide Price in 2026
Tirzepatide is the molecule in Mounjaro and Zepbound — and there’s no generic, so what you pay depends entirely on the brand and the route. Here are the real prices: list, savings card and cash-pay, by brand and dose, with the trade-offs.
The short answer
Tirzepatide’s cash list price is about $1,086/mo (Zepbound) and $1,069/mo (Mounjaro) — but almost nobody pays that. With commercial insurance a savings card can cut it to ~$25/mo; uninsured patients can buy LillyDirect Zepbound vials from ~~$299/mo; and compounded tirzepatide runs from about $69/mo (not FDA-reviewed).
Tirzepatide price by brand & route
| Brand | Approved for | List price | With savings card | Cash-pay floor |
|---|---|---|---|---|
| Zepbound | Weight loss (obesity, OSA) | ~$1,086/mo | Reduced copay (commercial insurance) | LillyDirect self-pay vials ~$299–$699/mo |
| Mounjaro | Type 2 diabetes | ~$1,069/mo | As low as $25/mo (commercial + diabetes Dx) | No vial program; compare compounded or Zepbound vials |
| Compounded tirzepatide | Cash-pay (not FDA-reviewed) | — | Not applicable | from about $69/mo via telehealth |
Prices are estimates as of June 2026, set by manufacturers/providers and subject to change — confirm current pricing before buying. GLP1Zoom is not a pharmacy.
Compare cash-pay tirzepatide providers
SponsoredRanked by our editorial score. Visit a partner to check current cash-pay pricing and eligibility — we compare providers, we never sell medications.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
Go deeper on cost
Prices change — not medical advice
Compounded tirzepatide is the lowest-cost route but is not FDA-reviewed for safety, quality or effectiveness, and access has narrowed since the official shortages ended. Tirzepatide is prescription-only and carries a boxed warning for thyroid C-cell tumors. This page is educational, not medical advice. GLP1Zoom is an independent comparison site, not a pharmacy — always confirm the current price with the manufacturer or provider before purchasing.
Common questions about Tirzepatide price
How much does tirzepatide cost per month?
Tirzepatide is brand-only (there is no generic), so the price depends on the brand and how you pay. The cash list price is roughly $1,086/month for Zepbound and $1,069/month for Mounjaro. Almost nobody pays that: with commercial insurance a savings card can cut the copay to as little as $25/month (Mounjaro) or a reduced copay (Zepbound); uninsured patients can buy LillyDirect Zepbound self-pay vials from about ~$299/month; and compounded tirzepatide via telehealth runs about from about $69/month (not FDA-reviewed). Prices change often — confirm before buying.
What is the price of Mounjaro?
Mounjaro’s cash list price is about $1,069/month. It’s approved for type 2 diabetes, so the Mounjaro Savings Card can bring eligible commercially insured patients with a diabetes diagnosis to as little as $25/month. There is no LillyDirect self-pay vial program for Mounjaro (that’s Zepbound), so uninsured patients usually compare compounded tirzepatide or the Zepbound vial route for the same molecule.
What is the price of Zepbound?
Zepbound’s cash list price is about $1,086/month, but it’s uniquely cheaper to buy direct: Eli Lilly’s LillyDirect sells single-dose Zepbound vials self-pay from roughly $299–$699/month depending on strength — usually the cheapest FDA-approved tirzepatide route for the uninsured, no savings card needed. With commercial insurance, the Zepbound Savings Card reduces your copay.
How much is tirzepatide without insurance?
Ranked cheapest-first for cash-pay: compounded tirzepatide via telehealth from about $69/month (not FDA-reviewed); LillyDirect Zepbound self-pay vials ~$299–$699/month (FDA-approved brand); and the full ~$1,069–$1,086/month brand list price at a pharmacy without any program. Manufacturer savings cards don’t help the uninsured because they require commercial insurance.
Why is tirzepatide so expensive?
Tirzepatide is a newer, brand-only biologic (a dual GIP/GLP-1 agonist) with no generic competition, and it produced the largest weight loss of any GLP-1 in head-to-head trials — so manufacturer list prices sit near $1,000+/month. Competition from compounded versions and the manufacturer’s own cash-pay vial program is what actually pulls the real-world price down.
How we sourced these prices
List prices reflect publicly posted manufacturer WAC; cash-pay figures reflect the LillyDirect (Zepbound) self-pay vial program and typical telehealth compounded pricing as of June 2026; savings-card terms come from each manufacturer’s program. There is no generic tirzepatide. All prices change without notice — confirm current pricing with the manufacturer or provider before purchasing. Last reviewed 2026-06-26.